# Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans

> **NCT01354977** · PHASE2 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Insulin Resistance

## Interventions

- **DRUG:** Resveratrol

## Key facts

- **NCT ID:** NCT01354977
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2017-09-15
- **Final completion:** 2017-09-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354977, "Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01354977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*